Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 15 studies | 71% ± 16% | |
| oligodendrocyte precursor cell | 13 studies | 53% ± 15% | |
| astrocyte | 7 studies | 34% ± 17% | |
| GABAergic neuron | 6 studies | 31% ± 13% | |
| interneuron | 4 studies | 38% ± 3% | |
| neuron | 3 studies | 44% ± 15% | |
| glutamatergic neuron | 3 studies | 32% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 14 studies | 33% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 1645.05 | 2567 / 2642 | 87% | 7.24 | 615 / 705 |
| pancreas | 94% | 307.62 | 307 / 328 | 76% | 2.65 | 135 / 178 |
| intestine | 82% | 281.16 | 796 / 966 | 71% | 2.62 | 374 / 527 |
| stomach | 83% | 250.50 | 299 / 359 | 60% | 2.26 | 172 / 286 |
| prostate | 83% | 272.26 | 204 / 245 | 59% | 3.22 | 295 / 502 |
| adrenal gland | 84% | 424.85 | 216 / 258 | 42% | 2.21 | 97 / 230 |
| spleen | 94% | 378.41 | 226 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 38% | 98.38 | 549 / 1445 | 48% | 1.76 | 87 / 183 |
| skin | 31% | 72.91 | 564 / 1809 | 45% | 1.31 | 212 / 472 |
| breast | 51% | 256.99 | 236 / 459 | 13% | 0.34 | 147 / 1118 |
| thymus | 38% | 83.24 | 247 / 653 | 9% | 0.18 | 53 / 605 |
| bladder | 10% | 14.48 | 2 / 21 | 33% | 1.12 | 164 / 504 |
| lung | 2% | 3.80 | 14 / 578 | 32% | 1.06 | 365 / 1155 |
| kidney | 15% | 29.94 | 13 / 89 | 16% | 0.38 | 144 / 901 |
| ovary | 2% | 4.28 | 4 / 180 | 26% | 0.59 | 110 / 430 |
| uterus | 15% | 28.09 | 25 / 170 | 10% | 0.29 | 47 / 459 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.81 | 4 / 29 |
| heart | 11% | 22.61 | 99 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.42 | 5 / 45 |
| liver | 1% | 1.71 | 3 / 226 | 8% | 0.29 | 31 / 406 |
| peripheral blood | 5% | 10.64 | 50 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 11.61 | 59 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 3% | 7.60 | 42 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
| muscle | 0% | 0.74 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042391 | Biological process | regulation of membrane potential |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005249 | Molecular function | voltage-gated potassium channel activity |
| Gene name | KCNH8 |
| Protein name | Potassium voltage-gated channel subfamily H member 8 (ELK1) (hElk1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Voltage-gated potassium channel subunit Kv12.1) Potassium voltage-gated channel subfamily H member 8 |
| Synonyms | |
| Description | FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium channel. Elicits a slowly activating, outward rectifying current. Channel properties may be modulated by cAMP and subunit assembly. |
| Accessions | Q96L42 ENST00000328405.7 [Q96L42-1] ENST00000452398.5 F8WCG6 |
